UroGen Pharma Ltd. (URGN)

UroGen Pharma Revenue

UroGen Pharma had revenue of $50.96M in the quarter ending March 31, 2026, with 151.60% growth. This brings the company's revenue in the last twelve months to $140.49M, up 52.92% year-over-year. In the year 2025, UroGen Pharma had annual revenue of $109.79M with 21.45% growth.

• Revenue (ttm): $140.49M
• Revenue Growth: +52.92%
• P/S Ratio: 9.28
• Revenue / Employee: $471,453
• Employees: 298
• Market Cap: 1.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	109.79M	19.39M	21.45%
Dec 31, 2024	90.40M	7.69M	9.29%
Dec 31, 2023	82.71M	18.36M	28.52%
Dec 31, 2022	64.36M	16.32M	33.96%
Dec 31, 2021	48.04M	36.24M	307.17%
Dec 31, 2020	11.80M	11.78M	65,450.00%
Dec 31, 2019	18.00K	-1.11M	-98.40%
Dec 31, 2018	1.13M	-7.03M	-86.17%
Dec 31, 2017	8.16M	-9.37M	-53.46%
Dec 31, 2016	17.53M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error